IM Cannabis Prices $1.31M Registered Direct Offering at $2.00/Share
IMCC sits 87% above its 52-week low of $1.55 on elevated volume (11× avg).
Summary
IM Cannabis priced a $1.31M registered direct offering at $2.00 per share, a steep discount to the current price, with possible related-party participation and reliance on financial hardship exemptions.
Updates
· SEC 424B5 — The 424B5 prospectus supplement discloses the offering price of $2.00 per share, gross proceeds of approximately $1.3 million, and expected closing on September 24, 2026.
Key Events · Financing and Capital Events · IMCC
-
Registered Direct Offering Priced
655,000 common shares sold at $2.00 per share for gross proceeds of approximately $1.31 million, closing expected September 24, 2026.
-
Deep Discount to Market
The $2.00 offering price is 31% below the current $2.90 share price, reflecting the company's weak bargaining position.
-
Related-Party Participation
One or more purchasers may be a related party; the company intends to rely on MI 61-101 financial hardship exemptions, requiring board determination of serious financial difficulty.
-
Use of Proceeds
Net proceeds earmarked for working capital and general corporate purposes, including evaluating potential additional business opportunities.
Analysis · IMCC · Life Sciences
A $1.31 million raise via 655,000 shares at $2.00 each—a 31% discount to the current $2.90 price—signals continued cash burn and reliance on dilutive convertible notes. The offering includes a related-party disclosure: one or more buyers may be insiders, and the board is invoking financial hardship exemptions under Canadian rules. That combination—a discounted raise, insider participation, and a formal declaration of serious financial difficulty—tells investors the company is still fighting for survival.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1052 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IMCC was trading at $2.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $1.55 to $77.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.